Robust in vivo gene editing in mouse hepatocytes with systemic lipid nanoparticle delivery of CRISPR/Cas9 components

被引：0
|
作者：
Finn, J. D. [1 ]
Patel, M. [1 ]
Smith, A. Rhoden [1 ]
Shaw, L. [1 ]
Youniss, M. [1 ]
Ciullo, C. [1 ]
van Heteren, J. [1 ]
Lescarbeau, R. [1 ]
Seitzer, J. [1 ]
Growe, J. [1 ]
Dombrowski, C. [1 ]
Strapps, W. R. [1 ]
Barnes, T. M. [1 ]
Morrissey, D. V. [1 ]
机构：
[1] Intellia Therapeut, Cambridge, MA USA
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P280
引用
收藏
页码：A131 / A131
页数：1
相关论文
共 50 条
  • [11] Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing
    Im, San Hae
    Jang, Mincheol
    Park, Ji-Ho
    Chung, Hyun Jung
    JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
  • [12] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [13] Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9
    Cheng, Ranran
    Peng, Jin
    Yan, Yonghong
    Cao, Peili
    Wang, Jiewei
    Qiu, Chen
    Tang, Lichun
    Liu, Di
    Tang, Li
    Jin, Jianping
    Huang, Xingxu
    He, Fuchu
    Zhang, Pumin
    FEBS LETTERS, 2014, 588 (21) : 3954 - 3958
  • [14] A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
    Finn, Jonathan D.
    Smith, Amy Rhoden
    Patel, Mihir C.
    Shaw, Lucinda
    Youniss, Madeleine R.
    van Heteren, Jane
    Dirstine, Tanner
    Ciullo, Corey
    Lescarbeau, Reynald
    Seitzer, Jessica
    Shah, Ruchi R.
    Shah, Aalok
    Ling, Dandan
    Growe, Jacqueline
    Pink, Melissa
    Rohde, Ellen
    Wood, Kristy M.
    Salomon, William E.
    Harrington, William F.
    Dombrowski, Christian
    Strapps, Walter R.
    Chang, Yong
    Morrissey, David V.
    CELL REPORTS, 2018, 22 (09): : 2227 - 2235
  • [15] Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
    Hyemin Ju
    Dongyoon Kim
    Yu-Kyoung Oh
    Asian Journal of Pharmaceutical Sciences, 2022, 17 (05) : 641 - 652
  • [16] Gene editing in mouse zygotes using the CRISPR/Cas9 system
    Wefers, Benedikt
    Bashir, Sanum
    Rossius, Jana
    Wurst, Wolfgang
    Kuehn, Ralf
    METHODS, 2017, 121 : 55 - 67
  • [17] Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
    Ju, Hyemin
    Kim, Dongyoon
    Oh, Yu-Kyoung
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 17 (05) : 641 - 652
  • [18] In Vivo Editing of Macrophages through Systemic Delivery of CRISPR-Cas9-Ribonucleoprotein-Nanoparticle Nanoassemblies
    Lee, Yi-Wei
    Mout, Rubul
    Luther, David C.
    Liu, Yuanchang
    Castellanos-Garcia, Laura
    Burnside, Amy S.
    Ray, Moumita
    Tonga, Gulen Yesilbag
    Hardie, Joseph
    Nagaraj, Harini
    Das, Riddha
    Phillips, Erin L.
    Tay, Tristan
    Vachet, Richard W.
    Rotello, Vincent M.
    ADVANCED THERAPEUTICS, 2019, 2 (10)
  • [19] In vivo gene editing in mice through systemic delivery of CRISPR/Cas9-ribonucleoprotein
    Lee, Yi-Wei
    Luther, David
    Liu, Yuanchang
    Castellanos, Laura
    Hardie, Joseph
    Vachet, Richard
    Rotello, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [20] Nanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing
    Sharma, Bhawna
    Chauhan, Iti
    Kumar, Gaurav
    Bhardwaj, Khushboo
    Tiwari, Raj Kumar
    MICRORNA, 2024,
12345